Wockhardt Ltd. is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with a more than half of its revenue coming from Europe. The Company has a market capitalisation of over INR4,800 crore (US$1.07 billion) and an annual turnover of INR3,600 crore (US$802.8 million). It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 7,000 people globally. Wockhardt Hospitals is a subsidiary of the Wockhardt Group.
Wockhardt was founded by Habil Khorakiwala in the early 1960s. His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973. Wockhardt Ltd. was incorporated on July 8.1999. Wockhardt is often confused as a multinational because of its German sounding name.
Wockhardt is the first company outside of the US and Europe to manufacture recombinant human insulin.
